AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

INVEX THERAPEUTICS LTD

0.090

0.000

Volume:- -

Turnover:- -

Market Cap:6.76M

PE:59.56

High:0.090

Open:0.090

Low:0.090

Close:0.090

Loading ...

Overview Company News Filings

Company Profile

Company Name:

INVEX THERAPEUTICS LTD

Exchange:

ASX

Establishment Date:

2019

Employees:

- -

Office Location:

38 Rowland Street,Level 2,Subiaco,Perth,Western Australia,Australia

Website:

http://www.invextherapeutics.com

Zip Code:

6008

Phone:

Fax:

- -

Introduction:

Invex Therapeutics Ltd, a biopharmaceutical company, engages in the research and development of treatments for neurological conditions in Australia. It is involved in developing Exenatide, a treatment for neurological conditions derived from or involving raised intracranial pressure, such as idiopathic intracranial hypertension, acute stroke, and traumatic brain injury. The company was incorporated in 2019 and is based in Subiaco, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/IXC.AU/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IXC.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IXC.AU\",,,,,undefined,":{"symbol":"IXC.AU","market":"AU","secType":"STK","nameCN":"INVEX THERAPEUTICS LTD","latestPrice":0.09,"timestamp":1753078320000,"preClose":0.09,"halted":0,"volume":0,"delay":0,"nameEN":"INVEX THERAPEUTICS LTD","floatShares":48158225,"shares":75153848,"eps":0.001511,"marketStatus":"Not Yet Opened","change":0,"latestTime":"07-21 16:12:00 AEST","open":0.09,"high":0.09,"low":0.09,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.001511,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1753142400000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.09,"openAndCloseTimeList":[[1753056000000,1753077600000]],"volumeRatio":0,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IXC.AU\",,,,,undefined,":{"symbol":"IXC.AU","floatShares":48158225,"roa":"-1.20%","roe":"2.14%","lyrEps":-0.0218,"shares":75153848,"dividePrice":0,"high":0.09,"amplitude":0,"preClose":0.09,"low":0.09,"week52Low":0.059,"pbRate":"1.26","psRate":"5.58","week52High":0.1,"institutionHeld":0,"latestPrice":0.09,"eps":0.001511,"divideRate":0,"volume":0,"delay":0,"ttmEps":0.001511,"open":0.09,"prevYearClose":0.066,"prevWeekClose":0.09,"prevMonthClose":0.089,"prevQuarterClose":0.089,"fiveDayClose":0.09,"twentyDayClose":0.087,"sixtyDayClose":0.07},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":614309842,"yearFounded":2019,"address":"38 Rowland Street,Level 2,Subiaco,Perth,Western Australia,Australia","zipCode":"6008","officePhone":"61 8 6382 0137"},"stockCompanyDetail":{"websiteUrl":"http://www.invextherapeutics.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0.0345},{"period":"3month","weight":0.2857},{"period":"6month","weight":0.25},{"period":"1year","weight":0.1842},{"period":"ytd","weight":0.3636}],"compareEarnings":[{"period":"1week","weight":0.0117},{"period":"1month","weight":0.0105},{"period":"3month","weight":0.0814},{"period":"6month","weight":0.1207},{"period":"1year","weight":0.207},{"period":"ytd","weight":0.1537}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Invex Therapeutics Ltd, a biopharmaceutical company, engages in the research and development of treatments for neurological conditions in Australia. It is involved in developing Exenatide, a treatment for neurological conditions derived from or involving raised intracranial pressure, such as idiopathic intracranial hypertension, acute stroke, and traumatic brain injury. The company was incorporated in 2019 and is based in Subiaco, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.042814},{"month":2,"riseRate":0.5,"avgChangeRate":-0.047862},{"month":3,"riseRate":0.666667,"avgChangeRate":0.147696},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.015989},{"month":5,"riseRate":0,"avgChangeRate":-0.16993},{"month":6,"riseRate":0.5,"avgChangeRate":-0.019783},{"month":7,"riseRate":0.666667,"avgChangeRate":0.054104},{"month":8,"riseRate":0.666667,"avgChangeRate":0.006761},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.04445},{"month":10,"riseRate":0.5,"avgChangeRate":0.055335},{"month":11,"riseRate":0.5,"avgChangeRate":0.06393},{"month":12,"riseRate":0.833333,"avgChangeRate":0.053153}],"exchange":"ASX","name":"INVEX THERAPEUTICS LTD","nameEN":"INVEX THERAPEUTICS LTD"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"IXC.AU\",market:\"AU\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IXC.AU\",params:#limit:5,,,undefined,":[{"date":"2023-12-08","symbol":"IXC.AU","amount":0.1863,"announcedDate":"2023-11-30","type":"dividend","market":"AU","newRecordDate":"2023-12-11","defaultRemindTime":1701990000000,"name":"Invex Therapeutics","recordDate":"2023-12-18","payableDate":"2023-12-11","currency":"AUD","dateTimestamp":1701954000000,"payDate":"2023-12-18"},{"date":"2023-04-20","symbol":"IXC.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1681948800000,"name":null,"time":"","dateTimestamp":1681912800000,"actualEps":null},{"date":"2023-01-25","symbol":"IXC.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1674601200000,"name":null,"time":"","dateTimestamp":1674565200000,"actualEps":null},{"date":"2022-10-27","symbol":"IXC.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1666825200000,"name":null,"time":"","dateTimestamp":1666789200000,"actualEps":null},{"date":"2022-07-06","symbol":"IXC.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1657065600000,"name":null,"time":"","dateTimestamp":1657029600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IXC.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2023-12-08","recordDate":"2023-12-11","paymentDate":"2023-12-18","value":0.1863,"currency":"AUD"}]}}